| ROG | 13.48% | 258.50 | +0.58% | 311,608 | |
| NOVN | 13.39% | 92.29 | -1.12% | 874,171 | |
| NOVOb | 13.34% | 414.6 | -2.22% | 1,443,637 | |
| AZN | 13.31% | 10,294.0 | -0.17% | 687,902 | |
| SASY | 6.70% | 83.12 | -0.50% | 503,858 | |
| GSK | 5.00% | 1,348.00 | -4.60% | 1,837,226 | |
| ESLX | 4.90% | 243.80 | -0.16% | 131,802 | |
| HLN | 3.00% | 358.70 | -0.03% | 4,012,677 | |
| LONN | 2.97% | 569.80 | -0.04% | 32,018 | |
| ALCC | 2.56% | 70.14 | +0.66% | 221,850 |
SSgA SPDR ETFs Europe II Public Limited Company - SPDR MSCI Europe Health Care UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. It is co-managed by State Street Global Advisors France S.A. The fund invests in the public equity markets of developed countries in Europe. It seeks to invest in the stocks of companies operating in the health care sector. The fund invests in the stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI Europe Health Care Index, by investing in the stocks of companies as per their weightings in the index. The fund was formerly known as SPDR ETFs - SPDR MSCI Europe Health Care UCITS ETF. SSgA SPDR ETFs Europe II Public Limited Company - SPDR MSCI Europe Health Care UCITS ETF was formed on March 15, 2001 and is domiciled in Ireland.